FDA Approves Ixekizumab for Ankylosing Spondylitis Indication

Eli Lilly’s ixekizumab (Taltz) injection 80 mg/mL is now approved for the treatment of active ankylosing spondylitis.
— Read on www.specialtypharmacytimes.com/